Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Iain D. Dukes Insider Profile
4 Followers
Iain D. Dukes, Director at Iovance Biotherapeutics, holds 54.00K shares in Iovance Biotherapeutics (Ticker: IOVA), holds ― shares in Ikena Oncology (Ticker: IKNA), holds 1.78M shares in Traws Pharma (Ticker: TRAW). Most recently, Iain D. Dukes Bought ― shares of Iovance Biotherapeutics on Feb 20, 2024 for an estimated value of 292.80K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+84.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Iain D. Dukes holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 20, 2018 - Dec 20, 2019
Return:+261.70%
The most profitable trade made by Iain D. Dukes
Iain D. Dukes's Trading History
Iovance Biotherapeutics
Feb 20, 2024
Director
Informative Buy
292.80K
$675.00K
Ikena Oncology
―
Director
―
―
Theseus Pharmaceuticals
Feb 14, 2024
―
Uninformative Sell
―
$0.00
Traws Pharma
Apr 03, 2024
Executive Chairman, Director
Uninformative Buy
―
$1.17M
List of latest transactions for each holding click on a transaction to see Iain D. Dukes's performance on stock
You May Also Like
Iain D. Dukes insider profile FAQ
What is the percentage of profitable transactions made by Iain D. Dukes?
The percentage of profitable transactions made by Iain D. Dukes is 33%.
What is the average return per transaction made by Iain D. Dukes?
The average return per transaction made by Iain D. Dukes is 84.00%.
What stocks does Iain D. Dukes hold?
Iain D. Dukes holds: IOVA, IKNA, THRX, TRAW stocks.
What was Iain D. Dukes’s latest transaction?
Iain D. Dukes latest transaction was an Informative Buy of $292.80K.
What was Iain D. Dukes's most profitable transaction?
Iain D. Dukes’s most profitable transaction was an Informative Buy of IOVA stock on December 20, 2018. The return on the trade was 261.70%.
What is Iain D. Dukes's role in Iovance Biotherapeutics?
Iain D. Dukes's role in Iovance Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.